BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25670521)

  • 1. Organic anion transporting polypeptide-mediated transport of, and inhibition by, asunaprevir, an inhibitor of hepatitis C virus NS3 protease.
    Eley T; Han YH; Huang SP; He B; Li W; Bedford W; Stonier M; Gardiner D; Sims K; Rodrigues AD; Bertz RJ
    Clin Pharmacol Ther; 2015 Feb; 97(2):159-66. PubMed ID: 25670521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting the Contribution of OATP1B1 to Hepatic Uptake of Statins Using the OATP1B1 Selective Inhibitor Estropipate.
    Zhang Y; Panfen E; Fancher M; Sinz M; Marathe P; Shen H
    Mol Pharm; 2019 Jun; 16(6):2342-2353. PubMed ID: 31039308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a potential transporter-mediated drug interaction between rosuvastatin and pradigastat, a novel DGAT-1 inhibitor.
    Kulmatycki K; Hanna I; Meyers D; Salunke A; Movva A; Majumdar T; Natrillo A; Vapurcuyan A; Rebello S; Sunkara G; Chen J
    Int J Clin Pharmacol Ther; 2015 May; 53(5):345-55. PubMed ID: 25740267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different interaction profiles of direct-acting anti-hepatitis C virus agents with human organic anion transporting polypeptides.
    Furihata T; Matsumoto S; Fu Z; Tsubota A; Sun Y; Matsumoto S; Kobayashi K; Chiba K
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4555-64. PubMed ID: 24867984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pitavastatin is a more sensitive and selective organic anion-transporting polypeptide 1B clinical probe than rosuvastatin.
    Prueksaritanont T; Chu X; Evers R; Klopfer SO; Caro L; Kothare PA; Dempsey C; Rasmussen S; Houle R; Chan G; Cai X; Valesky R; Fraser IP; Stoch SA
    Br J Clin Pharmacol; 2014 Sep; 78(3):587-98. PubMed ID: 24617605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of organic anion transporting polypeptide 1B1 and 1B3 humanized mice as a translational model to study the pharmacokinetics of statins.
    Salphati L; Chu X; Chen L; Prasad B; Dallas S; Evers R; Mamaril-Fishman D; Geier EG; Kehler J; Kunta J; Mezler M; Laplanche L; Pang J; Rode A; Soars MG; Unadkat JD; van Waterschoot RA; Yabut J; Schinkel AH; Scheer N
    Drug Metab Dispos; 2014 Aug; 42(8):1301-13. PubMed ID: 24855184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil.
    Treiber A; Schneiter R; Häusler S; Stieger B
    Drug Metab Dispos; 2007 Aug; 35(8):1400-7. PubMed ID: 17496208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver.
    Vavricka SR; Van Montfoort J; Ha HR; Meier PJ; Fattinger K
    Hepatology; 2002 Jul; 36(1):164-72. PubMed ID: 12085361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of hepatic uptake transporters by flavonoids.
    Mandery K; Balk B; Bujok K; Schmidt I; Fromm MF; Glaeser H
    Eur J Pharm Sci; 2012 May; 46(1-2):79-85. PubMed ID: 22394605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of organic anion transporting polypeptide (OATP) 1B1 and OATP1B3 to hepatic uptake of nateglinide, and the prediction of drug-drug interactions via these transporters.
    Takanohashi T; Kubo S; Arisaka H; Shinkai K; Ubukata K
    J Pharm Pharmacol; 2012 Feb; 64(2):199-206. PubMed ID: 22221095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-drug interactions between rosuvastatin and oral antidiabetic drugs occurring at the level of OATP1B1.
    van de Steeg E; Greupink R; Schreurs M; Nooijen IH; Verhoeckx KC; Hanemaaijer R; Ripken D; Monshouwer M; Vlaming ML; DeGroot J; Verwei M; Russel FG; Huisman MT; Wortelboer HM
    Drug Metab Dispos; 2013 Mar; 41(3):592-601. PubMed ID: 23248200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data.
    Kunze A; Huwyler J; Camenisch G; Poller B
    Drug Metab Dispos; 2014 Sep; 42(9):1514-21. PubMed ID: 24989890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3.
    Noé J; Portmann R; Brun ME; Funk C
    Drug Metab Dispos; 2007 Aug; 35(8):1308-14. PubMed ID: 17470528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The new acyl-CoA cholesterol acyltransferase inhibitor SMP-797 does not interact with statins via OATP1B1 in human cryopreserved hepatocytes and oocytes expressing systems.
    Kitamura A; Imai S; Yabuki M; Komuro S
    Biopharm Drug Dispos; 2007 Dec; 28(9):517-25. PubMed ID: 17918775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the impact of substrate selection on in vitro organic anion transporting polypeptide 1B1 inhibition profiles for the prediction of drug-drug interactions.
    Izumi S; Nozaki Y; Maeda K; Komori T; Takenaka O; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2015 Feb; 43(2):235-47. PubMed ID: 25414411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Culture duration-, donor-, and medium-dependent changes in OATP1B3-mediated telmisartan uptake in human hepatocytes.
    Zhu Q; Xia H; Xia CQ; Yang Q; Doshi U; Li AP; Liao M
    Drug Metab Lett; 2014 Jul; 7(2):117-25. PubMed ID: 24628404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport.
    Kindla J; Müller F; Mieth M; Fromm MF; König J
    Drug Metab Dispos; 2011 Jun; 39(6):1047-53. PubMed ID: 21389119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of genetic variants of Na(+)-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors.
    Choi MK; Shin HJ; Choi YL; Deng JW; Shin JG; Song IS
    Xenobiotica; 2011 Jan; 41(1):24-34. PubMed ID: 20946088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical Mouse Models To Study Human OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions in Vivo.
    Durmus S; Lozano-Mena G; van Esch A; Wagenaar E; van Tellingen O; Schinkel AH
    Mol Pharm; 2015 Dec; 12(12):4259-69. PubMed ID: 26474710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-drug interaction between pitavastatin and various drugs via OATP1B1.
    Hirano M; Maeda K; Shitara Y; Sugiyama Y
    Drug Metab Dispos; 2006 Jul; 34(7):1229-36. PubMed ID: 16595711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.